跳至主要内容
临床试验/CTRI/2018/03/012389
CTRI/2018/03/012389已完成未知

An open label clinical study to evaluate the safety, tolerability and glycemic index of COCOZEN in healthy volunteers

Akay Flavours and Aromatics Private Limited0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Males and females in the age 18 â?? 55 years
  • 2)Normal physical condition as determined by the investigator
  • 3)Subject with body mass index 18.5- 27 Kg/m2 (Both inclusive)
  • 4)Must be willing to comply with all study requirement
  • 5)Subject should agree to avoid any kind of herbal formulations during the study period
  • 6)Must be able and willing to provide a written informed consent.

排除标准

  • 1)Subject with history of cardiovascular, Type 2 Diabetes mellitus, pulmonary, hepatic and renal problems
  • 2)Subjects who are currently under any kind of long term medication
  • 3)Subjects with a known allergy to herbal products
  • 4)Chronic drinkers
  • 5)Subject with a habit of smoking
  • 6)Subjects with abnormal biochemical or haematological values
  • 7)Subjects with abnormal blood pressure
  • 8)Pregnant or Lactating Women
  • 9)Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study.

研究者

发起方
Akay Flavours and Aromatics Private Limited

相似试验